Immunophenotyping in a COVID-19 Cohort (IMPACC) Transcriptomics and Genotyping Assays
Demographics (3)
- SEX - Biological sex (phv00556904.v1.p2)
- SEX - Biological sex (phv00508623.v3.p2)
- SUBJECT_AGE - Subject Age (phv00508627.v2.p2)
Other (21)
- ANALYTE_TYPE - Analyte Type (phv00508634.v3.p2)
- BODY_SITE - Body site where sample was collected (phv00508633.v3.p2)
- COHORT - Covid-19 status at enrollment (phv00508628.v2.p2)
- CONSENT - Consent group as determined by DAC (phv00508622.v3.p2)
- FAMILY_ID - Family ID (phv00556900.v1.p2)
- FATHER - Father's Subject ID (phv00556902.v1.p2)
- IS_TUMOR - Tumor status (phv00508635.v3.p2)
- MOTHER - Mother's Subject ID (phv00556903.v1.p2)
- MZ_TWIN_ID - Twin ID for monozygotic twins and multiples. An MZ_TWIN_ID is not provided for dizygotic twins or multiples. (phv00556905.v1.p2)
- RESPIRATORY_STATUS_DAY14 - Ordinal score for respiratory status at day 14 of study (phv00556908.v1.p2)
- RESPIRATORY_STATUS_DAY28 - Ordinal score for respiratory status at day 28 of study (phv00556909.v1.p2)
- SAMPLE_ID - Sample ID (phv00508630.v3.p2)
- SAMPLE_ID - Sample ID (phv00508625.v3.p2)
- SAMPLE_TYPE - Assay type that generated the sample (phv00508632.v3.p2)
- SUBJECT_ID - Subject ID (phv00508626.v2.p2)
- SUBJECT_ID - Subject ID (phv00556901.v1.p2)
- SUBJECT_ID - Subject ID (phv00508621.v3.p2)
- SUBJECT_ID - Subject ID (phv00508624.v3.p2)
- TRAJECTORY_GROUP_2021 - Assigned trajectory group based on recovery 2021 (phv00556906.v1.p2)
- TRAJECTORY_GROUP_2023 - Assigned trajectory group based on recovery 2023 (phv00556907.v1.p2)
- VISIT_ID - The relative timepoint the sample was taken at (phv00508631.v3.p2)